(Q35581727)

9 August 2017

1 reference

title

T-cell immunotherapy of allergic disease: the role of CD8+ T cells (English)

1 reference

9 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

31 March 2024

1

Graham S Ogg

1 reference

9 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14612672

31 March 2024

publication date

1 December 2003

1 reference

full work available at URL

9 August 2017

https://journals.lww.com/00130832-200312000-00009

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Current Opinion in Allergy and Clinical Immunology

31 March 2024

published in

1 reference

9 August 2017

volume

3

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

475-479

1 reference

Prediction of murine MHC class I epitopes in a major house dust mite allergen and induction of T1-type CD8+ T cell responses

9 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization

31 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Different profile of CD8+ effector T cells induced in Der p 1-allergic and naïve mice by DNA vaccination

31 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppres

31 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Antigen-specific CD8+ T cells inhibit IgE responses and interleukin-4 production by CD4+ T cells

31 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Depletion of CD8+ T cells following primary immunization with ovalbumin results in a high and persistent IgE response

31 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

T cytotoxic 1 and T cytotoxic 2 CD8 T cells both inhibit IgE responses

31 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Overexpression of IL-15 in vivo enhances Tc1 response, which inhibits allergic inflammation in a murine model of asthma.

31 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

CD8 T cells inhibit IgE via dendritic cell IL-12 induction that promotes Th1 T cell counter-regulation

31 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a marine model of airway sensitization

31 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia

31 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Intracellular cytokine expression in whole blood preparations from normals and patients with atopic dermatitis

31 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy

31 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Increased circulating skin-homing cutaneous lymphocyte-associated antigen (CLA)+ type 2 cytokine-producing cells, and decreased CLA+ type 1 cytokine-producing cells in atopic dermatitis

31 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test

31 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis

31 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Selective CD8+ T cells accumulate in the lungs of patients with allergic asthma after allergen bronchoprovocation

31 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Cytokine mRNA expression in patients with mild allergic asthma following low dose or cumulative dose allergen provocation

31 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Increase in perforin-positive peripheral blood lymphocytes in extrinsic and intrinsic asthma

31 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Distribution and cytokine production of CD4 and CD8 T-lymphocyte subsets in patients with acute asthma attacks

31 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Increased bronchoalveolar lavage CD8 lymphocyte subset population in wheezy infants

31 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Activated, cytotoxic CD8(+) T lymphocytes contribute to the pathology of asthma death

31 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Secretion of the eosinophil‐active cytokines interleukin‐5, granulocyte/macrophage colonystimulating factor and interleukin‐3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopics asthmatics, and atopic and nonatopic controls

31 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Inhaled glucocorticoid therapy of childhood asthma is associated with reduced peripheral blood T cell activation and 'Th2-type' cytokine mRNA expression

31 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Peripheral blood CD4+ and CD8+ T cell type 1 and type 2 cytokine production in atopic asthmatic and normal subjects.

31 March 2024

30

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Increased frequency of intracellular interleukin (IL)-13 and IL-10, but not IL-4, expressing CD4+ and CD8+ peripheral T cells of patients with atopic dermatitis

31 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Intracellular IL-5 and T-lymphocyte subsets in atopic and nonatopic bronchial asthma

31 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.

31 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

TCR usage and cytokine expression in peripheral blood and BAL T cells

31 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalv

31 March 2024

35

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Allergen-specific CD8(+) T cells and atopic disease

31 March 2024

36

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy.

31 March 2024

37

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Isotypic and idiotypic characterization of anti-bee venom phospholipase A2 antibodies.

31 March 2024

38

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

31 March 2024

39

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Dose response of IgE and IgG antibodies during ragweed immunotherapy

31 March 2024

40

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Changes in nasal metachromatic cells during allergen immunotherapy

31 March 2024

41

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity

31 March 2024

42

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy

31 March 2024

43

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients

31 March 2024

44

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Grass pollen immunotherapy decreases the number of mast cells in the skin.

31 March 2024

45

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium.

31 March 2024

46

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.

31 March 2024

47

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

31 March 2024

48

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

31 March 2024

49

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Long-term clinical efficacy of grass-pollen immunotherapy

31 March 2024

50

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

31 March 2024

51

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Role of interleukin 10 in specific immunotherapy

31 March 2024

52

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

31 March 2024

53

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Specific immunotherapy downregulates peripheral blood CD4 and CD8 T-lymphocyte activation in grass pollen-sensitive asthma

31 March 2024

54

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

31 March 2024

57

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Effects of peptide therapy on ex vivo T-cell responses

31 March 2024

58

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells

31 March 2024

59

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Generation of Antigen-Specific Suppressor Cells during Allergy Desensitization

31 March 2024

60

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Generation of suppressor cells in atopic patients during immunotherapy that modulate IgE synthesis

31 March 2024

61

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Allergen-specific production of interferon-gamma by peripheral blood mononuclear cells and CD8 T cells in allergic disease and following immunotherapy

31 March 2024

62

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

T-cell cytokine pattern at three time points during specific immunotherapy for mite-sensitive asthma

31 March 2024

63

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Glucocorticoids drive human CD8(+) T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production

31 March 2024

64

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Wasp venom immunotherapy induces a shift from IL-4-producing towards interferon-gamma-producing CD4+ and CD8+ T lymphocytes.

31 March 2024

65

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Specific immunotherapy prevents increased levels of allergen-specific IL-4- and IL-13-producing cells during pollen season

31 March 2024

66

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Proliferation and release of IL-5 and IFN-gamma by peripheral blood mononuclear cells from cat-allergic asthmatics and rhinitics, non-cat-allergic asthmatics, and normal controls to peptides derived from Fel d 1 chain 1

31 March 2024

67

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios.

31 March 2024

68

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial

31 March 2024

69

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects

31 March 2024

70

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells

31 March 2024

71

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Oligoclonal analysis of the atopic T cell response to the group 1 allergen of Cynodon dactylon (bermuda grass) pollen: pre- and post-allergen-specific immunotherapy

31 March 2024

72

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Application of heat killed Mycobacterium bovis-BCG into the lung inhibits the development of allergen-induced Th2 responses

31 March 2024

73

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production.

31 March 2024

74

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

31 March 2024

75

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract

31 March 2024

76

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

The effect of specific immunotherapy on T‐cell receptor repertoire in patients with allergy to house‐dust mite

31 March 2024

77

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy

31 March 2024

78

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Injection of soluble antigen into the anterior chamber of the eye induces expansion and functional unresponsiveness of antigen-specific CD8+ T cells

31 March 2024

79

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells

31 March 2024

80

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

In situ tetramer staining

31 March 2024

81

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00009

31 March 2024

Identifiers

1 reference

9 August 2017

1 reference